Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib
Jacqueline Barrientos, MD from Northwell Health, New York, NY discuss a placebo-controlled study of idelalisib in combination with bendamustine plus rituximab, also known as BR (NCT01569295). The resu...
Author: VJHemOnc
Added: 07/05/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts